Biotech

Israeli life sciences investments fell 40% in 2025, report found

Investments in Israeli life sciences companies fell sharply in 2025, dropping 40% after a recovery the previous year, according to a report by the Israel Advanced Technology Industries Association.

In the photo (from left): Karin Mayer Rubinstein, CEO and President of the Israel Advanced Technology Industries Association (IATI), and Dror Bin, CEO of the Israel Innovation Authority.
 The four-story ‘Clore Person, with inflatable organs that are activated by climbing inside the giant statue

Startup wants to grow “headless humans” to replace lab animals

Noam Solomon, CEO of Immunai, is using AI technology to map a key part of the human physiology – the immune system – and help discover and develop therapeutics that will ultimately save lives.

Israeli mathematician uses AI to decode human immune system

Visitors walk across salt formations along the receding shoreline of the Dead Sea, a stark sign of the region’s growing environmental crisis.

Israel's overlooked challenge: Environmental damage from two years of war - from the editor


3D bioprinting tech to be licensed by Tel Aviv University

The technology was used to print a heart made of human cells and extracellular matrix at TAU in 2019.

A 3D printed, small-scaled human heart engineered from the patient’s own materials and cells.

New method for mapping gene expression could be used alongside cancer therapy - study

Findings by Israeli scientists may completely change the way we approach observing the biological processes of the human body in the future.  

 Bar-Shir team - Dr. Amnon Bar-Shir and Dr. Hyla Allouche-Arnon

Israeli biotech company paves a new way in healing injured spinal cords

The company successfully used human implants for replacing the injured spinal cord of a living pig, thereby simulating the anticipated surgical procedure in humans.

 Piglets at a pig farm.